Regarding the mechanism of how the high levels of LDL-C led to an increased MetS risk, previous studies suggested that the increased levels of serum apolipoprotein-B and circulating oxidized LDL might contribute to endothelial dysfunction and vascular inflammation by increasing the LDL-C levels [18–21]. The gene discussed is APOB; the disease is endothelial dysfunction.